[1]
T. Nazir, S. Farhat, M. Adil, and Z. Asraf, “Adverse drug reactions associated with first line anti-tubercular drugs, their prevalence and causality assessment in patients on Directly Observed Treatment Short-course (DOTS) in a tertiary care hospital”, Int J Basic Clin Pharmacol, vol. 8, no. 1, pp. 147–152, Dec. 2018.